Literature DB >> 28624531

The short- to mid-term symptom prevalence of dumping syndrome after primary gastric-bypass surgery and its impact on health-related quality of life.

Marloes Emous1, Bruce H R Wolffenbuttel2, Eric Totté3, André P van Beek2.   

Abstract

BACKGROUND: Early and late dumping are complications of gastric bypass surgery. Early dumping occurs within an hour after eating, when the emptying of food into the small intestine triggers rapid fluid shifts into the intestinal lumen and the release of gastrointestinal hormones, resulting in gastrointestinal and vasomotor symptoms. Late dumping occurs between 1 and 3 hours after carbohydrate ingestion and is caused by an exaggerated insulin release, resulting in hypoglycemia. Almost no data are currently available on the prevalence of early and late dumping or their impact on health-related quality of life (QoL).
OBJECTIVES: To study the prevalence of early and late dumping in a large population of patients having undergone a primary Roux-en-Y gastric bypass (RYGB) and its effect on QoL.
SETTING: Cross-sectional study at a single bariatric department in the Medical Center Leeuwarden, The Netherlands between 2008 and 2011.
METHODS: In 2013, this descriptive cohort study approached by email or post all patients who underwent a primary RYGB in the setting between 2008 and 2011 in one hospital. These patients were asked to fill in standardized questionnaires measuring their QoL (RAND-36), anxiety and depression (HADS), fatigue (MFI-20) and any disease specific indicators of early and late dumping syndrome.
RESULTS: The questionnaire was completed and returned by 351 of 613 patients (57.1%) and 121 nonobese volunteers. Participants were mostly female (80%), aged 42 (40-54 years), with an excess weight loss of 76.8% [IQR 61-95] after RYGB surgery 2.3 [ IQR 1.6-3.4] years earlier. Self-reported complaints of moderate to severe intensity suggestive of early and late dumping were present in 18.8% and 11.7% of patients, respectively. Patients with early and late dumping demonstrated significantly lower scores on the RAND-36 and HADS compared with patients without dumping. No differences were seen in the MFI-20 scores between patients with or without early and late dumping.
CONCLUSION: In this descriptive cohort, self-reported complaints suggestive of early and late dumping of moderate-to-severe intensity were, respectively, 18.8% and 11.7% in a cohort after primary gastric bypass surgery. These complaints were associated with markedly reduced health-related QoL.
Copyright © 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Early dumping; Gastric bypass; Late dumping; Post-gastric bypass hypoglycemia; Quality of life

Mesh:

Year:  2017        PMID: 28624531     DOI: 10.1016/j.soard.2017.04.028

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  17 in total

1.  A Real-World, Insurance-Based Algorithm Using the Two-Fold Running Suture Technique for Transoral Outlet Reduction for Weight Regain and Dumping Syndrome After Roux-En-Y Gastric Bypass.

Authors:  Lea Fayad; Michael Schweitzer; Micheal Raad; Cem Simsek; Roberto Oleas; Margo K Dunlap; Tazkia Shah; Jay Doshi; Margueritta El Asmar; Andreas Oberbach; Vikesh K Singh; Kimberly Steele; Thomas Magnussen; Anthony N Kalloo; Mouen A Khashab; Vivek Kumbhari
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

2.  Heterogeneity in the Definition and Clinical Characteristics of Dumping Syndrome: a Review of the Literature.

Authors:  Ben Gys; Philip Plaeke; Bas Lamme; Thierry Lafullarde; Niels Komen; Anthony Beunis; Guy Hubens
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

Review 3.  Current treatments for obesity.

Authors:  Aruchuna Ruban; Kostadin Stoenchev; Hutan Ashrafian; Julian Teare
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

4.  Health-Related Quality of Life 5 Years After Roux-en-Y Gastric Bypass in Young (18-25 Years) Versus Older (≥ 26 Years) Adults: a Scandinavian Obesity Surgery Registry Study.

Authors:  Helena Dreber; Anders Thorell; Signy Reynisdottir; Erik Hemmingsson
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

5.  Defining Short-term, Medium-term, Long-term, and Very Long-term Follow-up After Bariatric Surgery.

Authors:  Kamal K Mahawar
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

6.  Postprandial hypoglycemia after gastric bypass surgery: from pathogenesis to diagnosis and treatment.

Authors:  Henri Honka; Marzieh Salehi
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2019-07       Impact factor: 4.294

7.  Tailoring limb length based on total small bowel length in one anastomosis gastric bypass surgery (TAILOR study): study protocol for a randomized controlled trial.

Authors:  Nienke Slagter; Loek J M de Heide; Ewoud H Jutte; Mirjam A Kaijser; Stefan L Damen; André P van Beek; Marloes Emous
Journal:  Trials       Date:  2022-06-22       Impact factor: 2.728

8.  Endoscopic revision of gastrojejunal anastomosis for the treatment of dumping syndrome in patients with Roux-en-Y gastric bypass: a systematic review and meta-analysis.

Authors:  Ahmad Najdat Bazarbashi; Russell D Dolan; Thomas R McCarty; Pichamol Jirapinyo; Christopher C Thompson
Journal:  Surg Endosc       Date:  2021-10-20       Impact factor: 3.453

9.  Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.

Authors:  Caroline C Øhrstrøm; Dorte Worm; Urd Lynge Kielgast; Jens Juul Holst; Dorte L Hansen
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

10.  Altered bile acid kinetics contribute to postprandial hypoglycaemia after Roux-en-Y gastric bypass surgery.

Authors:  Merel van den Broek; Loek J M de Heide; Fianne L P Sips; Martijn Koehorst; Tim van Zutphen; Marloes Emous; Martijn van Faassen; Albert K Groen; Natal A W van Riel; Jan F de Boer; André P van Beek; Folkert Kuipers
Journal:  Int J Obes (Lond)       Date:  2021-01-15       Impact factor: 5.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.